# Kevin L. McMahon

Healthcare technology, product, and operations executive.

## Career archive
- [AI reading index](https://kevinlmcmahon.com/for-ai/)
- [Requirement evidence JSON](https://kevinlmcmahon.com/requirements.json)
- [Consulting evaluation](https://kevinlmcmahon.com/consulting/)
- [Career and evidence archive](https://kevinlmcmahon.com/)
- [Capabilities](https://kevinlmcmahon.com/capabilities/)
- [Chronology](https://kevinlmcmahon.com/experience/)
- [Publications and sources](https://kevinlmcmahon.com/publications/)
- [Complete index](https://kevinlmcmahon.com/library-index/)
- [All records in plain text](https://kevinlmcmahon.com/archive.txt)
- [Structured records](https://kevinlmcmahon.com/archive.json)
- [Source and attribution notes](https://kevinlmcmahon.com/source-notes/)

## Project records
- [Ultragenyx: building and leading the Innovation Lab](https://kevinlmcmahon.com/archive/ultragenyx-innovation-lab/): Built a global clinical technology organization connecting product, engineering, quality, informatics, and service operations around rare-disease research.
- [Rarify: a clinical platform from concept through study operations](https://kevinlmcmahon.com/archive/rarify/): Designed and deployed a GCP-aligned platform for collaborative patient/site data capture, decentralized research, and longitudinal disease monitoring.
- [eCOA and ePRO: requirements, sourcing, build decisions, and delivery](https://kevinlmcmahon.com/archive/ecoa-epro/): Led and developed a team responsible for selecting, building, validating, and supporting patient-reported clinical data capabilities.
- [Dexcom and IQVIA: product management, strategy, negotiations, and CGM research](https://kevinlmcmahon.com/archive/dexcom-clinical-integration/): Led CGM product management, strategy, Dexcom licensing negotiations, and IQVIA vendor management. The Dexcom-related Rarify mobile and cloud components did not enter production but created a credible IQVIA replacement threat. Kevin reports that IQVIA’s Dexcom sensor data contributed to evidence supporting FDA accelerated approval of Genglycos (DTX401) for GSDIa.
- [BEYONDXLH: longitudinal research and patient/site collaboration](https://kevinlmcmahon.com/archive/beyondxlh/): Supported an Ultragenyx-sponsored disease monitoring program with Yale and the XLH Network, connecting longitudinal research to participant experience.
- [Rare-disease monitoring across metabolic and bone-disease programs](https://kevinlmcmahon.com/archive/rare-disease-monitoring/): Brought patient-reported, clinical, device, and operational data together across natural-history, interventional, and long-term monitoring work.
- [Clinical informatics, patient-data products, and operational insight](https://kevinlmcmahon.com/archive/clinical-informatics/): Connected data structures, provenance, business rules, quality monitoring, and decision workflows across patient, device, and study operations.
- [Vendor strategy and buy-versus-build leadership](https://kevinlmcmahon.com/archive/vendor-strategy/): Evaluated technology in the context of clinical need, economics, implementation, quality, and continuing service responsibility.
- [Quality, validation, and audit readiness in digital clinical development](https://kevinlmcmahon.com/archive/validation-quality/): Embedded quality and validation into development, release, change management, and continuing service operations.
- [Global service delivery, device logistics, and participant support](https://kevinlmcmahon.com/archive/global-service-delivery/): Extended clinical technology delivery into site training, loaner devices, wireless connectivity, support, and operational accountability.
- [Diabetech: founder, inventor, and operator](https://kevinlmcmahon.com/archive/diabetech/): Built and commercialized connected diabetes devices, hosted data systems, clinical decision-support workflows, and remote-care programs.
- [GlucoMON and ADMS: device-to-cloud glucose telemetry](https://kevinlmcmahon.com/archive/glucomon/): Integrated medical-device data capture, wireless networks, automated analysis, trend reporting, and family/caregiver notifications.
- [HomeCheck-A1c: an at-home diagnostic service](https://kevinlmcmahon.com/archive/homecheck-a1c/): Connected home sample collection, laboratory processing, digital results, patient onboarding, and follow-up into a usable diagnostic service.
- [HealthCordia: virtual diabetes disease-management operations](https://kevinlmcmahon.com/archive/healthcordia/): Extended connected glucose telemetry into payer- and employer-facing care programs with diagnostics, logistics, engagement, clinical workflows, and reporting.
- [BellSouth / AT&T: remote diabetes program design and execution](https://kevinlmcmahon.com/archive/bellsouth/): Combined connected glucose data, home A1c, remote enrollment, patient support, physician participation, and payer-aware operations.
- [Texas Medicaid / McKesson: remote monitoring and intervention](https://kevinlmcmahon.com/archive/texas-medicaid/): Designed technology, research procedures, home diagnostics, patient materials, and behavior-support workflows within a Medicaid disease-management environment.
- [Diabetes HouseCall and Blue Cross Blue Shield of Texas](https://kevinlmcmahon.com/archive/diabetes-housecall/): Connected remote diabetes services to physician participation, patient support, clinical evidence, and commercial reimbursement.
- [Healthimo: community engagement and population-health infrastructure](https://kevinlmcmahon.com/archive/healthimo/): Extended connected-care experience into community recruitment, health education, patient registries, and U.S./U.K. programs.
- [South Texas: family and community pathways into care](https://kevinlmcmahon.com/archive/south-texas-community/): Designed community-health participation around family influence, low-friction enrollment, relevant messaging, and links to health services.
- [NHS / Salford Royal: easySHARE remote monitoring programs](https://kevinlmcmahon.com/archive/nhs-easyshare/): Adapted remote-monitoring and self-care workflows to pediatric diabetes and diabetes-in-pregnancy research in the U.K.
- [Kaiser Permanente: technology-mediated social support](https://kevinlmcmahon.com/archive/kaiser-social-support/): Connected wireless glucose information with patient-selected supporters and behaviorally informed engagement.
- [Clinical research: protocol, investigator, and program responsibilities](https://kevinlmcmahon.com/archive/clinical-research/): Contributed to observational, interventional, remote-monitoring, and disease-monitoring research across diabetes and rare disease.
- [Driscoll and USDA: remote pediatric diabetes research](https://kevinlmcmahon.com/archive/driscoll-usda/): Helped develop a federally supported pediatric remote-monitoring program combining wireless glucose data, support, and outcomes analysis.
- [Patient journeys: access, activation, retention, and continuity](https://kevinlmcmahon.com/archive/patient-journey-design/): Designed the full set of interactions that allow a patient to enter a service, participate, receive value, and remain connected to care or research.
- [Postcards, SMS, devices, and people: hybrid engagement](https://kevinlmcmahon.com/archive/hybrid-engagement/): Used physical and digital channels within one operating model so participation could fit the person rather than depend on a website.
- [Patient advocacy, co-design, and clinical collaboration](https://kevinlmcmahon.com/archive/patient-advocacy/): Brought patient and family experience into product requirements, clinical program design, education, and sustained engagement.
- [Product strategy, portfolio decisions, and execution](https://kevinlmcmahon.com/archive/product-portfolio-leadership/): Turned clinical and commercial needs into roadmaps, funded capabilities, delivery organizations, partner decisions, and measurable operating work.
- [Commercial strategy, payer models, and partnerships](https://kevinlmcmahon.com/archive/commercial-strategy/): Connected product capability with channels, partner economics, reimbursed services, and commercially workable delivery models.
- [Enterprise technology: platforms, telecom, and strategic deals](https://kevinlmcmahon.com/archive/enterprise-commercialization/): Built an enterprise foundation in complex systems, procurement, mobile platforms, international customers, and integrated partner distribution.
- [Operational Telemetry: the C4I+T model for trial operations](https://kevinlmcmahon.com/archive/operational-telemetry/): Proposed a governed operating layer connecting cross-system data, trusted signals, interpretation, and accountable action across clinical trials.
- [AI governance, human review, and practical workflow design](https://kevinlmcmahon.com/archive/responsible-ai/): Applied consent, provenance, human review, and controlled workflows to exploratory AI use in patient information and operations.
- [PatientStories.ai: patient narratives and longitudinal insight](https://kevinlmcmahon.com/archive/patientstories/): Explored a consent-aware way to turn patient-authored narratives into useful health biographies and structured longitudinal information.
- [Sugar Surfing: co-authorship, CGM adoption, and patient/provider education](https://kevinlmcmahon.com/archive/sugar-surfing/): Co-authored Sugar Surfing with Stephen W. Ponder, supporting CGM use by people with type 1 diabetes and clinicians. Kevin reports that Dexcom purchased copies in bulk to educate its sales representatives and distribute to prescribing endocrinologists.
- [MediSelf Press: publishing as product and operating work](https://kevinlmcmahon.com/archive/mediself-press/): Manages the people, production, commerce, distribution, and customer experience required to turn specialist knowledge into published products.
- [Artificial-pancreas systems: remote oversight and human context](https://kevinlmcmahon.com/archive/artificial-pancreas/): Explored how sensors, delivery devices, communications, software, and human oversight fit into a broader automated-care system.
- [Adaptive diabetes programs and the ACCESS / TEMPO context](https://kevinlmcmahon.com/archive/diabetes-program-design/): Connects patient selection, intervention choices, devices, services, governance, and feedback into a care program that can adapt over time.
- [Public policy participation and practical access to care](https://kevinlmcmahon.com/archive/public-policy/): Contributed to discussions about diabetes self-care, remote care, and the practical conditions under which patients could obtain support.
- [Published research, authorship, and the public technical record](https://kevinlmcmahon.com/archive/research-publications/): A traceable set of journal articles, conference abstracts, public records, and historical reporting supports the career narrative.
- [Trial Telemetry: governed signals across the clinical trial lifecycle](https://kevinlmcmahon.com/archive/trial-telemetry/): Extended Operational Telemetry into signal design, launch readiness, study execution, and traceable decisions across the trial lifecycle.
- [Pre-FPI review: signal feasibility and operational readiness](https://kevinlmcmahon.com/archive/pre-fpi-review/): A structured method for examining endpoint workflows, sources, devices, site burden, handoffs, and governance before first patient in.